Diabulimia: Forced Weight Loss by Diabetics Can Kill

Diabulimia is a new term used to describe an eating disorder that’s beginning to victimize type I diabetics. As with any other eating disorder teens are the most likely to develop it. The complication is not limited to teenagers only. Any insulin dependent diabetic can become a victim. Diabulimia is developed when a type I diabetic begins to skip scheduled insulin injections as a means of weight loss.

Full article (237 words) »

What Matters Most To You & Me As A Blogger

Darren Rowse posted an interesting question: "What matters most to you as a blogger". Here's my answer:
1. Blog as repository of knowledge. I am an avid reader; I learn new things everyday. However I keep my RAM (quick search memory) very small. Consequently I frequently refer to my blog and then to Google to find something I discovered earlier (read: My brain is in Google). First and foremost I use the blog to jot down new information and knowledge I gather in course of my work and while browsing.

Full article (323 words) »

The Lies Of Embryonic Stem Cell Research Objections or One Woman With Two Souls Ridicules Religious Zealots

stem cell research Full article (444 words) »

Drug for Diabetic Nephropathy in Phase 3 Trial

Speedel announced today the start of its Phase III study for SPP301, its once-a-day oral endothelin A receptor antagonist (ERA) in the indication of diabetic nephropathy (diabetic kidney disease). The ASCEND(1) study has begun with the first patient visit as per the schedule outlined by Speedel in March 2005 when the company reported successful completion of the Phase II clinical trials.

Full article (226 words) »

Anouncement: The Stem Cell Blog - News and Hard Facts on Stem Cell Research and Treatment Options

We have forked of our coverage of Stem Cell Research news and views in our recently launched The Stem Cell Blog. You will find it much more active than it was under the folds of multi-faceted Simple Thoughts Blog.

Full article (193 words) »

Consolidated Health News for the week ending June 12, 2005

Three transplant patients have died as a result of receiving an organ from a donor who had unknowingly been infected with a common rodent virus. A fourth patient who received a kidney from the organ donor is recovering.

In what is believed to be only the second documented case in which the viral infection LCMV was transmitted through an organ transplant, four patients in all were infected and health officials say the infection has been traced to a female organ donor from Rhode Island who died of unrelated causes, but who was exposed to a common rodent virus, possibly from a pet hamster.

Full article (368 words) »

Rep. Senator Diana DeGette supports stem-cell research; Shouldn’t you too?

DeGette, a Denver Democrat, and Rep. Mike Castle, R-Del., are sponsoring a bill that would add new ethical standards and increase the number of lines of embryonic stem cells available for federally funded disease research. The bill is expected to come up for a vote in the House of Representatives on Tuesday.

Full article (236 words) »

Korean Study Demonstrates Feasibility of Efficiently Harvesting Genetically Identical Stem Cells from Egg Donors

Korean Scientists lead by Woo Suk Hwang and Shing Yong Moon of Seoul National University in Korea have successfully generated new lines of human embryonic stem cells that are exact genetic matches for individual patients, according to a new study.

Full article (335 words) »

Research discovers response to beta-blocker therapy genetically pre-determined - must read if you are on beta-blocker therapy

Dr. Julie JohnsonBeta-Blockers (like Atenolol) are used for heart failure treatment. Beta-blockers are also often prescribed for diabetic and renal (kidney) transplant recepients as adjunct anti-hypertensive (blood pressure) medications.

Beta-blockers help restore the heart to a more typical shape and size and improve heart function.
Some patients tolerate them well while others have difficulty and suffer adverse reactions such as shortness of breath, ankle swelling (edema) or fluid retention in the lungs, fatigue and reduced ability to tolerate exercise or even worsening of their heart failure symptoms.
Full article (375 words) »

Keryx announces positive interim results for mid stage trial drug for diabetic nephropathy treatment

Keryx Biopharmaceuticals (KERX) Announces Positive Interim Results From Phase 2 Clinical Study For KRX-101 (Sulodexide Gelcaps) For Treatment Of Diabetic Nephropathy.
Full article (112 words) »

Protected by Comment Guard Pro